Verdict: Side-by-side breakdown using the Bull Rankings model. ADUS scored 74.5, OPCH scored 70.3 — ADUS leads.
Compare another set
Different reporting periods. ADUS's fundamentals are as of June 2026, but OPCH's are as of March 2026 — a 3-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
ADUS
Addus HomeCare Corporation
Medical Care Facilities · Quality-Growth
74.5
$114.33 · $2.1B
fundamentals as of
Score gap
4.2
ADUS leads
OPCH
Option Care Health, Inc.
Medical Care Facilities · Quality-Growth
70.3
$31.07 · $4.7B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
CheapestADUS20.0x
Fastest growthADUS+23.2%
Strongest balance sheetADUS0.09
Highest qualityOPCH62 / 100
Largest discount to fair valueADUS-35%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
ADUS
stronger →← stronger
OPCH
59
Qualityreturns · margins · balance sheet
62
84
Growthrevenue & earnings expansion
79
84
Valuevaluation vs sector peers
71
ADUS is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
ADUS
OPCH
$155mC
FCF
$213mC
+23.2%A-
Rev
+13.0%B+
0.09B+
D/E
1.01C
20.0xB+
P/E
23.5xB+
1.00B+
PEG
1.49B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
ADUS
OPCH
35% below
Price vs fair valuelower is cheaper
19% below
~-1%/yr
Growth the price impliesyr-1 FCF growth, fading to 4% · lower = less priced in
~4%/yr
+35%
1-yr DCF upside
+10%
+53%
5-yr DCF upside
+24%
+83%
10-yr DCF upside
+49%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
ADUS
No notable signals flagged.
OPCH
Why this score
Buying back stock
The companies
ADUSAddus HomeCare Corporation
Medical Care Facilities · $114.33 · beta 0.83
Why now
Medical Care Facilities · market cap $2.1b. 8% off the 52-week high of $124.44. Revenue growing +23%, comfortably above the S&P median. 13 sell-side analysts rate this a Buy with a mean 1-yr target of $134.08 (implying +17% upside).
Moat
FCF converts 147% of net income — earnings translate cleanly into cash.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
OPCHOption Care Health, Inc.
Medical Care Facilities · $31.07 · beta 0.58
Why now
Medical Care Facilities · market cap $4.7b. 16% off the 52-week high of $36.80. Revenue growing +13%, comfortably above the S&P median. 8 sell-side analysts rate this a Hold with a mean 1-yr target of $29.52 (implying -5% upside).
Moat
ROE 15% is above 15% — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 103% of net income — earnings translate cleanly into cash.
Risk
Net margin 3.6% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
Verdict — model-derived comparison
The model slightly favors OPCH (75.8) over ADUS (75.7), partly due to its "Buying back stock" signal. However, a contrarian might prefer ADUS for its significantly stronger balance sheet, evidenced by a B+ grade for Debt/Equity (0.09) versus OPCH's C grade (1.01). No structural caveats apply as both stocks are in the same sector and use comparable scoring scales.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where ADUS and OPCH diverge
On the headline score the gap is 4.2 points in favor of ADUS. The widest single difference is Value, where ADUS leads by 12.8 points.
ValueADUS 83.6 · OPCH 70.8ADUS +12.8
GrowthADUS 83.6 · OPCH 79.3ADUS +4.3
QualityADUS 59.1 · OPCH 61.9level
Pillars run 0–100. Value is judged against each company's own sector, so a Value score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.
Common questions
Is ADUS or OPCH the better stock?
ADUS scores higher: ADUS 74.5, OPCH 70.3 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.
Where do ADUS and OPCH differ most?
The widest gap is value, where ADUS leads by 13 points on the 0–100 pillar scale. ADUS also leads growth, while quality is effectively level between them.
How are ADUS and OPCH scored?
Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.
How current is this comparison?
The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.